By Kathryn Hardison

Johnson & Johnson's Kenvue Inc., which will be its stand-alone company for consumer health brands, has filed for an initial public offering.

The offering is part of Kenvue's previously disclosed separation from Johnson & Johnson, which will continue to be the name of the company housing its prescription-drug and medical-devices units. Kenvue will oversee brands such as Band-Aid and Tylenol.

Kenvue has filed for an initial public offering with the Securities and Exchange Commission, though it didn't disclose the financial details of the planned offering in a Wednesday filing.

The company said that all of the net proceeds from the sale of shares in the offering will be paid to Johnson & Johnson.

Kenvue will apply to list its shares under the ticker KVUE.

Write to Kathryn Hardison at kathryn.hardison@wsj.com

(END) Dow Jones Newswires

January 04, 2023 17:19 ET (22:19 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Johnson and Johnson Charts.